UnitedHealth Group Dirección

Dirección controles de criterios 3/4

El CEO de UnitedHealth Group's es Andrew Witty , nombrado en Feb 2021, tiene una permanencia de 3.5 años. compensación anual total es $23.53M, compuesta por 6.4% salario y 93.6% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.011% de las acciones de la empresa, por valor de MX$1.08B. La antigüedad media del equipo directivo y de la junta directiva es de 2.9 años y 6 años, respectivamente.

Información clave

Andrew Witty

Chief Executive Officer (CEO)

US$23.5m

Compensación total

Porcentaje del salario del CEO	6.4%
Permanencia del CEO	3.6yrs
Participación del CEO	0.01%
Permanencia media de la dirección	3yrs
Promedio de permanencia en la Junta Directiva	6.1yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Andrew Witty en comparación con los beneficios de UnitedHealth Group?
Fecha	Compensación total	Salario	Ingresos de la empresa
Jun 30 2024	n/a	n/a	US$14b
Mar 31 2024	n/a	n/a	US$15b
Dec 31 2023	US$24m	US$2m	US$22b
Sep 30 2023	n/a	n/a	US$22b
Jun 30 2023	n/a	n/a	US$21b
Mar 31 2023	n/a	n/a	US$21b
Dec 31 2022	US$21m	US$2m	US$20b
Sep 30 2022	n/a	n/a	US$19b
Jun 30 2022	n/a	n/a	US$18b
Mar 31 2022	n/a	n/a	US$17b
Dec 31 2021	US$18m	US$1m	US$17b
Sep 30 2021	n/a	n/a	US$15b
Jun 30 2021	n/a	n/a	US$15b
Mar 31 2021	n/a	n/a	US$17b
Dec 31 2020	US$13m	US$419k	US$15b
Sep 30 2020	n/a	n/a	US$17b
Jun 30 2020	n/a	n/a	US$17b
Mar 31 2020	n/a	n/a	US$14b
Dec 31 2019	US$17m	US$1m	US$14b
Sep 30 2019	n/a	n/a	US$13b
Jun 30 2019	n/a	n/a	US$13b
Mar 31 2019	n/a	n/a	US$13b
Dec 31 2018	US$22m	US$613k	US$12b
Sep 30 2018	n/a	n/a	US$13b
Jun 30 2018	n/a	n/a	US$12b
Mar 31 2018	n/a	n/a	US$11b
Dec 31 2017	US$62k	n/a	US$11b

Compensación vs. Mercado: La compensación total de Andrew($USD23.53M) está por encima de la media de empresas de tamaño similar en el mercado MX ($USD6.10M).

Compensación vs. Ingresos: La compensación de Andrew ha sido consistente con los resultados de la empresa en el último año.

CEO

Andrew Witty (59 yo)

3.6yrs

Permanencia

US$23,534,936

Compensación

Sir Andrew Philip Witty has been the Chief Executive Officer and Non-Independent Director of UnitedHealth Group Incorporated since February 3, 2021 and served as its Group President since November 2019 unt...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Andrew Witty	CEO & Non-Independent Director	3.6yrs	US$23.53m	0.011% $ 1.1b
John Rex	President & CFO	8.3yrs	US$16.07m	0.019% $ 2.0b
Rupert Bondy	Senior Counsel & Executive VP of Governance	less than a year	US$6.42m	0.00042% $ 44.5m
Brian Thompson	Chief Executive Officer of UnitedHealthcare	no data	US$10.22m	0.0035% $ 374.7m
Thomas Roos	Senior VP & Chief Accounting Officer	9.1yrs	sin datos	0.0032% $ 333.5m
Sandeep Dadlani	Executive VP and Chief Digital & Technology Officer	2yrs	sin datos	sin datos
Zachary Sopcak	Senior Vice President of Capital Markets Communications & Investor Relations	2.5yrs	sin datos	sin datos
Chris Zaetta	Executive VP	less than a year	sin datos	0.00087% $ 92.1m
Jennifer Smoter	Senior VP & Chief Communications Officer	3.5yrs	sin datos	sin datos
James Barry	Director of Sales for Western Pennsylvania	no data	sin datos	sin datos
Terry Clark	Executive VP & Chief Marketing Officer	10.7yrs	sin datos	sin datos
Erin L. McSweeney	Executive VP & Chief People Officer	2.5yrs	sin datos	0.00085% $ 90.0m

3.0yrs

Permanencia media

59yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de UNH * se considera experimentado (2.9 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Andrew Witty	CEO & Non-Independent Director	3.6yrs	US$23.53m	0.011% $ 1.1b
Stephen Hemsley	Non-Independent Non-Executive Chairman	24.6yrs	US$595.35k	0.12% $ 12.2b
Michele Hooper	Lead Independent Director	16.9yrs	US$441.52k	0.00036% $ 38.1m
Paul Garcia	Independent Director	2.8yrs	US$366.80k	0.00033% $ 34.9m
Timothy Flynn	Independent Director	7.7yrs	US$400.16k	0.00038% $ 40.2m
Frederick McNabb	Independent Director	6.6yrs	US$392.88k	0.00070% $ 74.1m
John Noseworthy	Independent Director	5.6yrs	US$391.05k	0.00056% $ 59.3m
Valerie C. Rice	Independent Director	7.1yrs	US$391.05k	0.000040% $ 4.2m
Kristen Gil	Independent Director	1.8yrs	US$351.80k	0.000050% $ 5.3m
Charles Baker	Independent Director	less than a year	US$59.33k	sin datos

6.1yrs

Permanencia media

67.5yo

Promedio de edad

Junta con experiencia: La junta directiva de UNH * se considera experimentada (6 años de antigüedad promedio).

UnitedHealth Group Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Senior VP & Chief Accounting Officer recently sold Mex$29m worth of stock

UnitedHealth Group Incorporated Announces Management Changes, Effective June 4, 2024

UnitedHealth Group Incorporated, Annual General Meeting, Jun 03, 2024

Executive VP & Chief People Officer recently sold Mex$10m worth of stock

Senior VP & Chief Accounting Officer recently sold Mex$7.7m worth of stock

Executive VP & CEO of UnitedHealthcare recently sold Mex$209m worth of stock

Recent updates

New minor risk - Share price stability

UnitedHealth Group Incorporated to Report Q3, 2024 Results on Oct 15, 2024

Upcoming dividend of US$2.10 per share

Second quarter dividend of US$2.10 announced

UnitedHealth Group Authorizes Payment of Quarterly Dividend, Payable on September 24, 2024

Senior VP & Chief Accounting Officer recently sold Mex$29m worth of stock

Second quarter 2024 earnings released: EPS: US$4.54 (vs US$5.89 in 2Q 2023)

UnitedHealth Group Incorporated to Report Q2, 2024 Results on Jul 16, 2024

First quarter dividend of US$2.10 announced

UnitedHealth Group Announces Cash Dividend, Payable on June 25, 2024

New minor risk - Share price stability

UnitedHealth Group Incorporated Announces Management Changes, Effective June 4, 2024

First quarter 2024 earnings released: US$1.53 loss per share (vs US$6.01 profit in 1Q 2023)

UnitedHealth Group Incorporated, Annual General Meeting, Jun 03, 2024

New major risk - Financial position

First quarter 2024 earnings released: US$1.53 loss per share (vs US$6.01 profit in 1Q 2023)

UnitedHealth Group Incorporated Provides Earnings Guidance for the Full Year 2024

UnitedHealth Group Incorporated to Report Q1, 2024 Results on Apr 16, 2024

Court Substantially Denies United Healthcare’s Motion for Summary Judgment in ERISA Class Action: Case Moves to Trial

Executive VP & Chief People Officer recently sold Mex$10m worth of stock

Fourth quarter dividend of US$1.88 announced

Full year 2023 earnings released: EPS: US$24.12 (vs US$21.47 in FY 2022)

Senior VP & Chief Accounting Officer recently sold Mex$7.7m worth of stock

UnitedHealth Group Announces Quarterly Dividend, Payable on March 19, 2024

Executive VP & CEO of UnitedHealthcare recently sold Mex$209m worth of stock

Unitedhealth Group Incorporated Announces Retirement of Dirk McMahon as President and Chief Operating Officer, Effective April 1, 2024

Full year 2023 earnings released: EPS: US$23.86 (vs US$21.47 in FY 2022)

UnitedHealth Group Incorporated to Report Q4, 2023 Results on Jan 12, 2024

Unitedhealth Group Incorporated Provides Earnings Guidance for the Year 2023 and 2024

Upcoming dividend of US$1.88 per share at 1.4% yield

UnitedHealth Group Incorporated Announces Cash Dividend, Payable on December 12, 2023

UnitedHealth Group Incorporated Appoints Charlie Baker to Board of Directors

Unitedhealth Group Incorporated Announces Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings released: EPS: US$6.24 (vs US$5.63 in 3Q 2022)

Now 20% undervalued

UnitedHealth Group Incorporated to Report Q3, 2023 Results on Oct 13, 2023

Upcoming dividend of US$1.88 per share at 1.6% yield

Unitedhealth Group Board Authorizes Payment of Quarterly Dividend, Payable on September 19, 2023

CEO & Non-Independent Director recently sold Mex$34m worth of stock

UnitedHealth Group Incorporated Provides Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings released: EPS: US$5.82 (vs US$5.41 in 2Q 2022)

Now 20% undervalued after recent price drop

UnitedHealth Group Incorporated to Report Q2, 2023 Results on Jul 14, 2023

Unitedhealth Group Incorporated Announces Quarterly Cash Dividend, Payable on June 27, 2023

Now 20% undervalued after recent price drop

Mercy Investment Files an Exempt Solicitation and Urge Vote For its Proposal

Executive VP & Chief People Office recently sold Mex$24m worth of stock

First quarter 2023 earnings released: EPS: US$5.95 (vs US$5.34 in 1Q 2022)

Now 21% undervalued after recent price drop

Full year 2022 earnings released: EPS: US$21.47 (vs US$18.33 in FY 2021)

Now 20% undervalued after recent price drop

Full year 2022 earnings released: EPS: US$21.18 (vs US$18.33 in FY 2021)

UnitedHealth Group Incorporated to Report Q4, 2022 Results on Jan 13, 2023

Kristen Gil Joins Unitedhealth Group Incorporated Board of Directors

Executive VP & Chief People Office recently sold Mex$4.8m worth of stock

Upcoming dividend of US$1.65 per share

UnitedHealth Group Incorporated Authorizes Payment of Quarterly Dividend, Payable on December 13, 2022

Third quarter 2022 earnings released: EPS: US$5.55 (vs US$4.33 in 3Q 2021)

Unitedhealth Group Incorporated Increases Earnings Guidance for the Full Year 2022

Now 23% undervalued after recent price drop

Now 20% undervalued

Judge Denies U.S. Bid to Stop UnitedHealth Plan to Buy Change

UnitedHealth Group Incorporated to Report Q3, 2022 Results on Oct 14, 2022

Upcoming dividend of US$1.65 per share

Senior VP & Chief Accounting Officer recently sold Mex$5.0m worth of stock

Amazon Reportedly Among Bidders for Signify Health

President & COO recently sold Mex$160m worth of stock

UnitedHealth Group Announces Quarterly Dividend, Payable on September 20, 2022

CEO & Director recently sold Mex$123m worth of stock